Cue Biopharma

Latest Medical Device Stock News

Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases

June 2
Last Trade: 13.39 1.25 10.30

TORONTO, June 02, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced today that, with sponsorship and support from multiple physician specialty societies, the American Medical Association (“AMA”) has established three new Current...Read more


Microbot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic System

June 2
Last Trade: 1.76 -0.40 -18.52

HINGHAM, Mass., June 02, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic surgical system, announced it has received a grant from the Israel Innovation Authority ("IIA”) in the amount of NIS 1.62 million, which based on a recent exchange rate to the U.S. dollar, would be approximately $440,000, to further support the development...Read more


Senseonics Announces UnitedHealthcare Coverage of Eversense® E3 CGM for Adults with Diabetes

June 2
Last Trade: 0.74 0.10 16.15

Coverage policy expands access to the over 45 million lives covered by the largest healthcare insurance company in the United States GERMANTOWN, Md. / Jun 02, 2023 / Business Wire / Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that UnitedHealthcare,...Read more


NuGen Medical Devices Announces First Bulk Purchase Order for InsuJet(TM)

June 2
Last Trade: 0.20 -0.03 -11.11

Toronto, Ontario--(Newsfile Corp. - June 2, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce it has received its first bulk purchase order from Science-Link Trading SAPI de CV ("Science-Link"), a company in Mexico, for the Mexican market for 500 units of the Company's needle-free InsuJet™ injector device. The initial bulk purchase order for the 500 InsuJet™ devices is to be pre-paid in...Read more


Bruker to Present at Jefferies 2023 Healthcare Conference

June 2
Last Trade: 71.39 0.45 0.63

BILLERICA, Mass. / Jun 02, 2023 / Business Wire / Bruker Corporation (Nasdaq: BRKR) announced today it will present at the Jefferies 2023 Healthcare Conference in New York on Friday, June 9, 2023 at 9:00 am EDT. Presenting for the company will be Juergen Srega, President of the Bruker CALID Group. A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com....Read more


Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

June 2
Last Trade: 1.76 -0.40 -18.52

HINGHAM, Mass., June 02, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 701,756 shares of the Company’s common stock at a purchase price of $2.1375 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered...Read more


Ra Medical Systems Announces First Quarter Results

June 2
Last Trade: 1.05 -0.03 -2.78

FORT MILL, SC / ACCESSWIRE / June 2, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) today announced financial and company highlights for the first quarter ended March 31,2023. Among the quarter highlights are the following: RMED concluded the acquisition with the private, company Catheter Precision, Inc. ("Catheter"), in January 2023. Catheter is in the MedTech space of cardiac electrophysiology. Catheter onboarded five direct...Read more


Medtronic Names Ken Washington New Chief Technology and Innovation Officer

June 1
Last Trade: 83.76 1.01 1.22

DUBLIN, June 1, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced that Ken Washington, Ph.D., has been appointed Medtronic Chief Technology and Innovation Officer. In this newly created role, Dr. Washington will leverage his extensive experience leading technology development and execution across industries including robotics, consumer products, automotive, and space, to accelerate innovation-driven growth in service of the...Read more


CooperCompanies Announces Second Quarter 2023 Results

June 1
Last Trade: 356.47 -17.72 -4.74

SAN RAMON, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal second quarter ended April 30, 2023. Revenue increased 6% year-over-year to $877.4 million. CooperVision (CVI) revenue up 6% to $589.3 million, and CooperSurgical (CSI) revenue up 4% to $288.1 million. GAAP diluted earnings per share (EPS) of $0.80, down $1.75 or 69% from last year's second...Read more


Treace Medical Concepts to Acquire Technology Enabling Patient Specific Instrumentation for Foot and Ankle Surgeries

June 1
Last Trade: 26.78 0.27 1.02

PONTE VEDRA, Fla., June 01, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions), today announced that it has signed an asset purchase agreement to acquire certain assets of MIOS Marketing, LLC d/b/a RedPoint Medical3D (“RPM-3D”), a medical technology company...Read more


Viemed Healthcare Announces Successful Completion of HMP Acquisition

June 1
Last Trade: 9.80 -0.06 -0.61

LAFAYETTE, La., June 01, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced that it has successfully completed its previously announced acquisition of Tennessee based Home Medical Products, Inc. (“HMP”), a large regional provider of respiratory focused home medical solutions. “I’m...Read more


Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration

June 1
Last Trade: 320.86 6.62 2.11

Lightning Bolt™ 7 is the most advanced arterial thrombectomy system on the market Latest technology combines modulated aspiration with superior catheter design to maximize blood clot removal in a single session ALAMEDA, Calif., June 1, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, announced the U.S. Food and Drug Administration (FDA) clearance and launch of Lightning...Read more


Teleflex Awarded Agreements with Premier

June 1
Last Trade: 236.47 2.70 1.15

WAYNE, Pa., June 01, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded two group purchasing agreements with Premier, Inc. Effective July 1st, 2023, the new agreements allow Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Teleflex’s Central Venous and Arterial Vascular Access...Read more


Nexalin Technology and Wider Come Limited Announce Joint Venture Agreement to Advance Commercialization of Nexalin’s tACS Devices in the Asia Pacific Region

June 1
Last Trade: 0.89 -0.03 -3.50

HOUSTON, June 01, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced it has formalized a joint venture arrangement (“JV”) with Wider Come Limited (“Wider”). The JV, to be conducted through a company newly-formed under the laws of Hong Kong, will be engaged in the clinical development, marketing, sale and distribution of Nexalin’s second generation transcranial Alternating...Read more


Orthofix Medical Announces First Presentation of Seven-Year Outcome Data for the M6-C Artificial Cervical Disc With Other Clinical and Scientific Abstracts at the ISASS Annual Meeting

June 1
Last Trade: 19.89 1.11 5.91

LEWISVILLE, Texas / Jun 01, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the presentation of multiple clinical and scientific abstracts during the International Society for the Advancement of Spine Surgery (ISASS) annual meeting in San Francisco June 1-3, 2023. “We are pleased to support a wide range of abstracts and clinical data during the annual ISASS...Read more


Bausch + Lomb Announces Key Leadership Changes

June 1
Last Trade: 18.25 0.00 0.00

VAUGHAN, Ontario / Jun 01, 2023 / Business Wire / Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, announced a reshaping of its executive leadership team, including the elevation of all business unit heads. Luc Bonnefoy, senior vice president (SVP), Surgical; John Ferris, SVP, Consumer; and Yang Yang, SVP, Vision Care;...Read more


Dr. Maureen Dower Joins PetVivo Holdings as a Senior Technical Services Veterinarian

June 1
Last Trade: 2.09 0.04 1.95

MINNEAPOLIS, MN, US, June 01, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals and animal athletes is pleased to announce that Dr. Maureen Dower has accepted a position with the Company as its new Senior Technical Services Veterinarian. "We are thrilled to...Read more


Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference

May 31
Last Trade: 8.07 -0.12 -1.47

FREMONT, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming 44th Annual Goldman Sachs Healthcare Conference in Dana Point, CA. Cytek management is scheduled to participate in a fireside chat on Wednesday, June 14th at 3:20 p.m. Pacific Time / 6:20 p.m. Eastern Time. Interested parties may access a...Read more


Bruker to Host Investor Day on June 15th, 2023

May 31
Last Trade: 71.39 0.45 0.63

BILLERICA, Mass. / May 31, 2023 / Business Wire / Bruker Corporation (Nasdaq: BRKR) today announced the Company will host an Investor Day on June 15th, 2023, starting at 10:00 AM EDT, at Bruker’s Headquarters located at 40 Manning Road, Billerica, MA, with the live webcast starting at 11:00 AM EDT. Bruker’s 2023 Investor Day will provide a deeper look into the Company’s strategies and Project Accelerate 2.0 initiatives, with a particular...Read more


Microbot Medical: LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process

May 31
Last Trade: 1.76 -0.40 -18.52

HINGHAM, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular surgical robotic system, announces that an additional milestone was achieved when medical professionals experienced the Company's LIBERTY Robotic Surgical System as part of a formative study. The study was designed to enable medical professionals, including...Read more


IceCure's ProSense Installation in India is the First to Offer Cryoablation for the Treatment of Breast Cancer in the Country

May 31
Last Trade: 1.08 0.01 0.93

Latest system installation in IceCure's global commercial rollout of ProSense CAESAREA, Israel, May 31, 2023 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that ProSense was recently installed and inaugurated at Kovai Medical Center and Hospital...Read more


NeuroMetrix: Quell® Demonstrates Encouraging Clinical Trial Results in Chemotherapy Induced Peripheral Neuropathy (CIPN)

May 31
Last Trade: 1.03 0.02 1.98

WOBURN, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted publication of an abstract describing partial results from a NIH-funded, multi-site randomized controlled trial of Quell titled "Wireless transcutaneous electric nerve stimulation (TENS) for chemotherapy-induced peripheral neuropathy (CIPN): A proof-of-concept, placebo-controlled, randomized clinical trial (RCT)." The abstract will be published at the...Read more


Repligen Corporation to Present at Upcoming Investor Conferences

May 31
Last Trade: 167.26 0.19 0.11

WALTHAM, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at two upcoming investor conferences. William Blair’s 43rd Annual Growth Stock Conference being held in Chicago June 6-8. Tony J. Hunt, President and Chief Executive Officer, is scheduled to present a company overview on June 8, 2023 at...Read more


Telesis Bio Secures Financing of $28.0 Million

May 31
Last Trade: 1.45 -0.07 -4.61

Up to an Additional $46.2 Million Available Through Warrant Exercise Led by Novalis LifeSciences LLC with participation from Northpond Ventures, M-185 Corporation and BroadOak Capital Partners SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced it has signed a securities purchase agreement...Read more


Azenta to Participate in the Jefferies Healthcare Conference

May 30
Last Trade: 44.21 0.68 1.56

BURLINGTON, Mass., May 30, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Jefferies Healthcare Conference in New York, NY, on Thursday, June 8, 2023, which includes a presentation beginning at 11:30 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following...Read more


Establishment Labs Announces CE Mark Approval for Minimally Invasive Surgical Tools

May 30
Last Trade: 66.44 1.99 3.09

NEW YORK / May 30, 2023 / Business Wire / Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has received CE marking under the European Medical Device Regulation for the Motiva Injector®, the Motiva® Inflatable Balloon, and the Motiva® Channel Dissector. “The approval in Europe of our...Read more


STRATA Skin Sciences Announces First Patients Treated in TheraClear®X Clinical Study for Acne

May 30
Last Trade: 0.97 0.02 2.28

HORSHAM, Pa., May 30, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that the first six patients have been treated in the TheraClear®X open label, single-arm, clinical research study led by Glynis Ablon, MD, FAAD. The purpose of the study titled, “A...Read more


Ventripoint Diagnostics Receives European Union Medical Device Regulation Certification

May 30
Last Trade: 0.18 0.00 0.00

Toronto, ON - TheNewswire - May 30, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) is pleased to announce that it has successfully obtained European Union Medical Device Regulation (EU MDR) certification for its cardiac diagnostic system. This significant milestone further underscores Ventripoint’s dedication to delivering state-of-the-art diagnostic tools to healthcare professionals and...Read more


Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference

May 30
Last Trade: 83.76 1.01 1.22

DUBLIN, May 30, 2023 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual Goldman Sachs global healthcare conference on Monday, June 12, 2023. Geoff Martha, Medtronic chairman and chief executive officer, will answer questions on the company beginning at 10:40 a.m. PDT (12:40 p.m. CDT). A live webcast of the Q&A session will be available on June 12, 2023,...Read more


Data Presented at the 2023 American Academy of Dental Sleep Medicine and the American Thoracic Society Meetings Further Validate ProSomnus Precision Oral Appliance Therapy for the Treatment of Obstructive Sleep Apnea

May 30
Last Trade: 4.73 -0.10 -2.07

PLEASANTON, Calif., May 30, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (OSA), announced the presentation of four abstracts at the 2023 American Academy of Dental Sleep Medicine (AADSM) Annual Meeting, held May 19-21 in Philadelphia, Pennsylvania, and two abstracts at the American Thoracic Society (ATS) 2023 International Conference, held...Read more


908 Devices Features its High-Speed, High-Resolution Separations Technology at the 71st ASMS Conference

May 30
Last Trade: 9.09 0.34 3.89

Key oral presentation highlights the company’s prototype microfluidic chips for multi-omics workflows BOSTON / May 30, 2023 / Business Wire / 908 Devices Inc (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, is showcasing its ZipChip CE-MS device for rapid characterization of critical product quality attributes for biologics, oligonucleotides, RNAs, and AAVs, with an oral...Read more


Inspira Technologies Appoints Dr. Nir as Chief Medical Officer

May 30
Last Trade: 1.39 -0.01 -0.71

Dr. Nir is a clinical strategy expert with market experience RA'ANANA, Israel, May 30, 2023 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute respiratory care, has announced the appointment of Dr. Adi Rizansky Nir, PhD to the position of Chief Medical Officer ("CMO"). Dr. Nir brings a wealth of expertise...Read more


Theralase Technologies Releases 1Q2023 Interim Financial Statements

May 30
Last Trade: 0.25 0.00 0.00

TORONTO, ON / ACCESSWIRE / May 30 2023 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds ("PDCs") and their associated drug formulations intended to safely and effectively destroy various cancers has released the Company's 1Q2023 unaudited condensed interim consolidated Financial...Read more


BIOLASE Announces Closing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants

May 26
Last Trade: 0.09 0.0034 3.98

LAKE FOREST, Calif., May 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $50.00 per...Read more


electroCore Announces Departure of JP Errico from the Board of Directors

May 26
Last Trade: 4.79 -0.03 -0.62

ROCKAWAY, N.J., May 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the resignation of its Founder and former CEO, JP Errico from the Board of Directors. Mr. Errico will continue as a consultant and strategic advisor to the Company, focused on supporting the growth and direction of the wellness and human performance brands,...Read more


Medtronic to acquire wearable insulin patch maker EOFlow

May 25
Last Trade: 83.76 1.01 1.22

Acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support DUBLIN and SEONGNAM, South Korea, May 25, 2023 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd. (KOSDAQ: 294090), manufacturer of the EOPatch® device — a...Read more


Medtronic reports full year and fourth quarter fiscal 2023 financial results; announces dividend increase

May 25
Last Trade: 83.76 1.01 1.22

Mid-single digit fourth quarter revenue growth exceeded expectations on broad-based strength across the company DUBLIN, May 25, 2023 /CNW/ -- Medtronic plc (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year 2023, which ended April 28, 2023. Fourth Quarter (Q4) Key Highlights Q4 revenue of $8.5 billion increased 5.6% as reported and organic, ahead of expectations  Q4 GAAP diluted EPS of $0.88...Read more


Microbot Medical: Lahey Hospital & Medical Center Agrees to become One of the U.S. Sites for the LIBERTY® Robotic System’s First Human Trial

May 25
Last Trade: 1.76 -0.40 -18.52

This Significant Achievement Represents Major Progression Toward Regulatory and Commercialization Paths Additional Sites in the U.S. Are Expected to Participate in the Trial HINGHAM, Mass., May 25, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that it has successfully achieved another major milestone representing the next step toward the regulatory and commercial paths for the LIBERTY® Robotic Surgical...Read more


Therma Bright Expands U.S. Distribution of Venowave Device to Increase Sales Under Temporary CPT(R) & HCPCS Codes

May 25
Last Trade: 0.06 0.00 0.00

Toronto, Ontario--(Newsfile Corp. - May 25, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer and partner in a wide-range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to announce that the Company is working with its U.S distributor network on expanding sales of Venowave under the nine (9) temporary Current Procedural Terminology (CPT®) and Healthcare Common...Read more


New Data Out Of Cleveland Clinic Shows BioSig Technologies PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market

May 25
Last Trade: 1.32 -0.11 -7.69

WESTPORT, CT / ACCESSWIRE / May 25, 2023 / Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies' (NASDAQ:BSGM) proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in New Orleans, LA, last week. The platform's precision signal-capturing technology is meant to improve the speed, accuracy and precision of cardiac ablation, a widely-used surgery to treat atrial fibrillation. All...Read more


ResMed: 3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023

May 25
Last Trade: 220.64 1.95 0.89

France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP lowered all-cause mortality for PAP vs. non-PAP users with OSA Germany’s Michael Arzt presented new evidence that treating CSA with ASV* caused “a significant and clinically relevant improvement in disease-specific QoL, daytime sleepiness, and quality of sleep” WASHINGTON, May 25, 2023 (GLOBE NEWSWIRE) -- Renowned medical experts...Read more


Modular Medical Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares

May 25
Last Trade: 1.10 0.06 5.77

SAN DIEGO, CA / ACCESSWIRE / May 25, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that the underwriter of the Company's previously announced public offering has exercised in full its option to purchase an additional 1,322,534 shares of its...Read more


Salona Global Medical Device Announces Appointment of Lana Newishy to Board of Directors as Vice Chair and Enters into Financial Consulting Agreement

May 25
Last Trade: 0.27 0.01 3.85

SAN DIEGO, May 25, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global”, “SGMD” or the ‎‎“Company”) (TSXV:SGMD) is pleased to announce the appointment of Lana Newishy to its Board of Directors as Executive Vice Chair, effective May 24, 2023. Ms. Newishy is the former CFO of American Express Corporate Card Canada and most recently served as a senior executive in the Chief of Staff Office for the Global Supply...Read more


Baxter to Present at Jefferies Healthcare Conference

May 24
Last Trade: 41.33 0.10 0.24

DEERFIELD, Ill. / May 24, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023. José (Joe) Almeida, Baxter’s chairman, president and chief executive officer, is scheduled to present at 10:00 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through...Read more


iRhythm Technologies to Present at the William Blair 43rd Annual Growth Stock Conference

May 24
Last Trade: 105.66 -4.69 -4.25

SAN FRANCISCO, May 24, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming William Blair 43rd Annual Growth Stock Conference. iRhythm’s management is scheduled to present on Wednesday, June 7, at 4:00 p.m. Central Time. Those...Read more


Penumbra to Present at William Blair's 43rd Annual Growth Stock Conference

May 24
Last Trade: 320.86 6.62 2.11

ALAMEDA, Calif., May 24, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at William Blair's 43rd Annual Growth Stock Conference on Wednesday, June 7, 2023.   Event: William Blair's 43rd Annual Growth Stock Conference Date:  Wednesday, June 7, 2023 Time:  9:20am CT/ 7:20am PT A webcast of the...Read more


Tandem Diabetes Care to Present at the Jefferies Healthcare Conference

May 24
Last Trade: 24.77 0.21 0.86

SAN DIEGO / May 24, 2023 / Business Wire / Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the Jefferies Healthcare Conference on Thursday, June 8, 2023 at 1:30pm Eastern Time (10:30am Pacific Time). The Company update presentation will be webcast live, and an archive recording will be available for 30 days. The link to...Read more


ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

May 24
Last Trade: 7.77 0.07 0.91

SOLANA BEACH, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has entered into a multi-year license agreement with UCB (EURONEXT BRUSSELS: UCB), a global biopharmaceutical leader, to partner on drug delivery platforms for UCB’s gene therapy portfolio. “We are extremely excited to partner with...Read more


Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software

May 24
Last Trade: 278.30 -0.27 -0.10

Technology provides groundbreaking planning and guidance capabilities LEESBURG, Va. / May 24, 2023 / Business Wire / Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced that Early Product Surveillance (EPS) cases utilizing its Q Guidance System with Cranial Guidance Software are underway. The technology provides surgeons with image-based planning and an intraoperative guidance system designed to...Read more


European Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations

May 24
Last Trade: 104.20 1.38 1.34

MONITOR-HF is the third randomized, controlled trial globally to show a significant health benefit for indicated heart failure patients CardioMEMS is a paperclip-sized sensor that can remotely flag to a patient's clinical team the early warning signs of worsening heart failure ABBOTT PARK, Ill., May 24, 2023 /PRNewswire/ -- New data presented from an investigator-sponsored European trial found managing indicated1 heart failure...Read more


Azenta Announces Collaboration with the Lupus Research Alliance to Support the Advancement of Lupus Research and Drug Discovery

May 24
Last Trade: 44.21 0.68 1.56

Azenta has been Selected by the Lupus Research Alliance as its Sample Management Services Provider and Partner in Supporting the Development of the Patient Registry Component of the Lupus Nexus BURLINGTON, Mass., May 24, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced it has been selected by the Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics to support the development of the patient...Read more


Masimo Announces Major Expansion of the HEOS® Platform

May 24
Last Trade: 163.30 -2.02 -1.22

Secure Masimo Health Data Tracking Now Enabled on 4 Million Devices from Denon, Marantz, and Definitive Technology IRVINE, Calif. / May 24, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the global expansion of the HEOS platform, enabling an always-on connection to the Masimo Health secure cloud for four million devices and empowering consumers with an enhanced health tracking experience. This software upgrade allows...Read more


Align Technology to Speak at Upcoming Financial Conferences

May 24
Last Trade: 302.00 4.80 1.62

TEMPE, Ariz. / May 24, 2023 / Business Wire / Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. The presentations, as noted below, will...Read more


West Pharmaceutical to Participate in Upcoming Investor Conferences

May 24
Last Trade: 343.73 2.20 0.64

EXTON, Pa., May 24, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the William Blair 43rd Annual Growth Stock Conference in Chicago, IL on Tuesday, June 6, 2023 at 1:20pm CT. It will also present at the Jefferies Healthcare Conference in New York, NY on Wednesday, June 7, 2023 at 8:00 am ET. A live...Read more


Perspective Therapeutics to Present at the 2023 International Symposium on Radiopharmaceutical Sciences (iSRS)

May 24
Last Trade: 0.55 0.02 3.20

Three poster presentations from Perspective Therapeutics’ scientists and collaborators explore combinations of immunotherapy and targeted alpha-particle therapy in a malignant melanoma model, 203Pb manufacturing, and In Vivo Distribution of Recoiled 213Bi from [225Ac]Ac-DOTATATE RICHLAND, WASHINGTON & CORALVILLE, Iowa, May 24, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN:...Read more


Glaukos Announces Participation in the William Blair Growth Stock Conference

May 24
Last Trade: 62.12 3.29 5.59

ALISO VIEJO, Calif. / May 24, 2023 / Business Wire / Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the William Blair 43rd Annual Growth Stock Conference on Wednesday, June 7, 2023, at 10:40 a.m. CT in Chicago, IL. A live and...Read more


Helius Medical Technologies to Highlight Innovative PoNS Therapy™ at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting, in Commemoration of World MS Day

May 24
Last Trade: 0.16 0.0089 5.89

NEWTOWN, Pa., May 24, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies (Nasdaq:HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for gait deficits, is excited to announce its participation in the prestigious Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting.  The event, which coincides with the May 30 observance of World MS Day, will take place from May 31 to June 3 at the...Read more


Microbot Medical Announces Closing of $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

May 24
Last Trade: 1.76 -0.40 -18.52

HINGHAM, Mass., May 24, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has closed its previously announced registered direct offering for the purchase and sale of 1,209,500 shares of the Company’s common stock (or common stock equivalents) at a purchase price of $2.20 per share of common stock priced at-the-market under Nasdaq rules. H.C. Wainwright & Co. acted as the exclusive placement agent...Read more


Theralase Technologies Appoints Roger DuMoulin-White as President and Chief Executive Officer

May 24
Last Trade: 0.25 0.00 0.00

TORONTO, ON / ACCESSWIRE / May 24, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT) (OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light-activated Photo Dynamic Compounds ("PDCs") and their associated drug formulations, used to safely and effectively destroy various cancers, bacteria and viruses, is pleased to announce that Roger DuMoulin-White, B.Sc.,...Read more


NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales

May 24
Last Trade: 4.11 -0.29 -6.59

MOUNTAIN VIEW, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced the appointment of Ms. Kelley Nicholas as Vice President of Sales effective May 22, 2023. “I am thrilled to have Kelley Nicholas join NeuroPace as Vice President of Sales,” said Mike Favet, Chief Executive Officer of NeuroPace....Read more


Sanuwave Health Appoints Morgan Frank as Chief Executive Officer

May 24
Last Trade: 0.02 -0.0006 -3.73

Frank Brings 29 Years of Experience in Life Sciences, Technology, and Capital Markets Kevin Richardson to Remain at SANUWAVE as Chief Strategic Officer and as a Member of the Board of Directors EDEN PRAIRIE, MN, May 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB:SNWV), a leading provider of next-generation FDA-approved wound care products, today announced that its Board of...Read more


Aurora Spine Announces First Quarter Fiscal 2023 Financial Results

May 24
Last Trade: 0.30 -0.02 -6.25

CARLSBAD, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for its first quarter fiscal 2023 ended March 31, 2023. All figures are in U.S. dollars. Financial and Business Highlights Product mix – Sales of higher margin Aurora...Read more


Becton Dickinson Advances Prefilled Flush Syringe with Integrated 'Scrub-the-Hub' Innovation

May 23
Last Trade: 251.79 3.68 1.48

BD PosiFlush™ SafeScrub Streamlines Clinical Workflow for Disinfecting and Flushing IV Catheters to Help Improve Patient Care FRANKLIN LAKES, N.J., May 23, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced expanded customer availability of an all-in-one prefilled flush syringe with an integrated disinfection unit designed to reinforce compliance to infection...Read more


Paragon 28 Launches Comprehensive Supramalleolar Osteotomy System

May 23
Last Trade: 18.52 0.33 1.81

ENGLEWOOD, Colo. / May 23, 2023 / Business Wire / Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of its Gorilla® Supramalleolar Osteotomy (SMO) Plating and PRESERVE™ SMO Allograft System which were developed to provide surgeons versatility in plate selection and surgical approach for supramalleolar osteotomies. The system includes patent pending drilling and cutting guides to facilitate repeatable and controlled anterior...Read more


Artivion Announces FDA PMA Approval of PerClot and Transfer of PMA to Baxter

May 23
Last Trade: 15.29 0.52 3.52

Artivion to Receive $18.75 Million Milestone Payment Under Previously Announced Agreement Artivion to Begin Supplying Product to Baxter Under Transitional Manufacturing and Supply Agreement ATLANTA, May 23, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that the U.S. Food and Drug Administration (FDA) granted premarket application (PMA)...Read more


Sight Sciences Two Year Multicenter Study Results Show Sustained Reductions in Both Intraocular Pressure (IOP) and Glaucoma Medication Use in Mild-Moderate Primary Open Angle Glaucoma Patients Treated with a Procedure Enabled with the OMNI® Surgical...

May 23
Last Trade: 7.52 -2.04 -21.34

Retrospective Clinical Data from Seven US Sites Published in Clinical Ophthalmology Sustained and clinically meaningful IOP reductions observed at 12 months persisted through 24 months Sustained and clinically meaningful reductions in glaucoma medication use observed at 12 months also persisted through 24 months Confirmed safety and efficacy of OMNI Surgical System technology in both standalone and combination cataract...Read more


Stereotaxis: Advocate Christ Medical Center Extends Leadership in Heart Care with Adoption of Genesis Robotic Technology

May 23
Last Trade: 2.22 -0.05 -2.20

ST. LOUIS, May 23, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in robotic technologies for the treatment of cardiac arrhythmias, today announced the first treatment of patients with a newly launched Genesis Robotic Magnetic Navigation (RMN) system at Advocate Christ Medical Center in Chicago, Illinois. Advocate Christ Medical Center, a part of Advocate Health, is the leading provider of robotic heart rhythm care...Read more


CooperCompanies to Present at the Jefferies Healthcare Conference

May 23
Last Trade: 356.47 -17.72 -4.74

SAN RAMON, Calif., May 23, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Jefferies Healthcare Conference on Thursday, June 8, 2023. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the Company in a session scheduled to begin at 2:00 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at...Read more


Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

May 23
Last Trade: 1.76 -0.40 -18.52

HINGHAM, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 1,209,500 shares of the Company’s common stock (or common stock equivalents) at a purchase price of $2.20 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or...Read more


Microbot Medical Announces Closing of $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

May 23
Last Trade: 1.76 -0.40 -18.52

HINGHAM, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has closed its previously announced registered direct offering for the purchase and sale of 655,569 shares of the Company’s common stock at a purchase price of $2.20 per share of common stock priced at-the-market under Nasdaq rules. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The gross...Read more


BrainsWay Announces Appointment of Ido Marom as CFO

May 23
Last Trade: 1.72 -0.02 -1.09

BURLINGTON, Mass. and JERUSALEM, May 23, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the appointment of Ido Marom, an experienced senior financial leader in global industries, including medical technology, as Chief Financial Officer (CFO). Mr. Marom will succeed Scott...Read more


Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director

May 23
Last Trade: 0.49 0.03 6.27

REDWOOD CITY, Calif., May 23, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced Heiner Dreismann has joined its board of directors, effective immediately. Talis Bio also recently appointed Kim Popovits, who has served as a member...Read more


Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit

May 22
Last Trade: 1.45 -0.07 -4.61

SAN DIEGO, May 22, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its BioXp® Select DNA Cloning kit. The BioXp® Select DNA Cloning kit enables on-demand and automated assembly of DNA fragments via Gibson Assembly® or Golden Gate assembly cloning methods beginning from the customer’s linear DNA. The continued...Read more


Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism Patients

May 22
Last Trade: 62.23 -0.09 -0.14

IRVINE, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced planned enrollment of the PEERLESS II trial, Inari’s third randomized controlled trial (RCT) in venous thromboembolism (VTE). The trial design was presented at the Society for Cardiovascular Angiography &...Read more


Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians

May 22
Last Trade: 1.76 -0.40 -18.52

HINGHAM, Mass., May 22, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Surgical Robotic System, the first single-use endovascular robotic system, today announced a highly successful extended joint pre- clinical animal study held at a leading European-based research lab. A team of six leading European interventional radiologists utilized the system and performed a total of 48 catheterizations...Read more


Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India

May 22
Last Trade: 0.32 0.0056 1.81

SAN DIEGO, May 22, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today announced that it has received Ethics Review Board (ERB) approval from the Maulana Azad Medical College (MAMC), for a second site for its ongoing clinical trial of Aethlon's Hemopurifier® to treat severe COVID-19 in...Read more


New Data From iRhythm Technologies Reinforce the Utility of Long-Term Ambulatory Cardiac Monitoring for Increased Diagnostic Yield and Improved Diagnostic Accuracy of Actionable Arrhythmias

May 22
Last Trade: 105.66 -4.69 -4.25

SAN FRANCISCO, May 22, 2023 (GLOBE NEWSWIRE) -- Rhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today the presentation of four studies at the Heart Rhythm Society’s annual meeting, Heart Rhythm 2023, in New Orleans, LA. These new data reinforce the body of clinical evidence that long-term ambulatory cardiac monitoring...Read more


ZimVie to Present at the Stifel 2023 Jaws & Paws Conference

May 22
Last Trade: 9.90 0.17 1.75

WESTMINSTER, Colo., May 22, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that the company will be participating in the upcoming Stifel 2023 Jaws & Paws Conference in New York. Management will be hosting a presentation on Wednesday, May 31st, 2023, at 12:40 p.m. Eastern Time / 9:40 a.m. Pacific Time. Stifel’s Jaws & Paws is a leading conference...Read more


Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

May 22
Last Trade: 1.76 -0.40 -18.52

HINGHAM, Mass., May 22, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 655,569 shares of the Company’s common stock at a purchase price of $2.20 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about May 24, 2023, subject to the...Read more


Nano-X Imaging Announces First Quarter of 2023 Financial Results and Provides Business Update

May 22
Last Trade: 21.27 3.16 17.45

Reports progress towards global supply chain development Ended the first quarter of 2023 with cash, cash equivalents, restricted cash and marketable securities of $91.0 million Management to host conference call and webcast Monday, May 22, 2023 at 8:30 AM ET NEVE ILAN, Israel, May 22, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today...Read more


IceCure Medical Reports First Quarter 2023 Financial & Operational Results

May 22
Last Trade: 1.08 0.01 0.93

Physician Interest and Adoption of ProSense in the U.S. Builds Momentum as ProSense is Featured at Medical Conferences and Educational Courses ProSense was the only Cryoablation System Used in a First-of-its-Kind Cryotherapy Continuing Medical Education (CME) course at the American Society of Breast Surgeons (ASBrS) 2023 Annual Meeting Where a Plan was Presented for a Proposed ASBrS Cryoablation Trial Regulatory Approval Received in...Read more


Medtronic Extravascular ICD global clinical trial results reinforce device safety and effectiveness

May 20
Last Trade: 83.76 1.01 1.22

Late-breaking data at Heart Rhythm 2023 underscore performance of first-of-its-kind investigational defibrillator with the lead placed under the breastbone, outside the heart and veins Additionally, real-world analysis confirms long-term therapeutic benefit of commercially available ICDs DUBLIN and NEW ORLEANS, May 20, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced longer-term...Read more


Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies

May 20
Last Trade: 51.82 0.32 0.62

Additional real-world outcomes further demonstrate safety, efficacy and procedural reproducibility of the FARAPULSE™ Pulsed Field Ablation System* Results from global trial of the POLARx™ Cryoablation System* meet safety and effectiveness endpoints MARLBOROUGH, Mass., May 20, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company's key electrophysiology and cardiac rhythm...Read more


Abbott Laboratories Unveils Late-Breaking Data Showing the World's First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints

May 20
Last Trade: 104.20 1.38 1.34

Abbott's AVEIR™ DR i2i™ IDE study is the industry's first prospective study on the safety and performance of the world's first dual-chamber leadless pacemaker The study successfully met all three of its primary safety and performance endpoints Abbott's investigational AVEIR DR leadless pacemakers have been submitted for evaluation by the U.S. FDA NEW ORLEANS, May 20, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) today announced...Read more


Abbott Receives FDA Approval for TactiFlex™ Ablation Catheter for Treatment of Abnormal Heart Rhythm

May 19
Last Trade: 104.20 1.38 1.34

TactiFlex™ Ablation Catheter, Sensor Enabled™, is the world's first ablation catheter designed with a unique flexible electrode tip and contact force sensing to treat patients with atrial fibrillation When used with Abbott's EnSite™ X EP System, physicians have better visualization allowing for more accuracy and precision with the TactiFlex catheter, leading to reduced procedure times and better safety ABBOTT PARK, Ill., May 19,...Read more


Hologic Announces FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay

May 19
Last Trade: 79.06 -0.09 -0.11

Multiplexed Respiratory Test Now Available in the U.S. With New RespDirect Collection Kit MARLBOROUGH, Mass. / May 19, 2023 / Business Wire / Hologic Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Panther Fusion® SARS-CoV-2/Flu A/B/RSV assay. This assay is a molecular diagnostic test that detects and differentiates four of the most prevalent...Read more


Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope

May 19
Last Trade: 2.29 0.16 7.51

Study Presented at Heart Rhythm Society Supports Wound-Healing Benefits in Patients Receiving Cardiac Implantable Electronic Devices SILVER SPRING, Md., May 19, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today announced that positive data from the HEAL Study will...Read more


TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab

May 19
Last Trade: 10.59 0.25 2.42

MALVERN, Pa., May 19, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced it will be hosting its next cadaver lab on May 19 in Tampa, Florida. The upcoming program, “Advanced Hernia Repair with OviTex® Reinforced Tissue...Read more


Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms

May 19
Last Trade: 2.22 -0.05 -2.20

ST. LOUIS, May 19, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott’s EnSite™ X EP System with Stereotaxis’ Robotic Magnetic Navigation systems. The combination of Abbott’s leading cardiac mapping system with Stereotaxis’ advanced robotic technology brings together highly detailed real-time diagnostic information with the unprecedented precision and...Read more


Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

May 19
Last Trade: 0.24 0.02 8.44

ACTON, Mass., May 19, 2023 (GLOBE NEWSWIRE) --  Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announced an updated clinical and regulatory strategy for the Symphony IL-6 biomarker test to measure acuity in sepsis patients. The Company plans to modify the clinical...Read more


Sign Up To Get Daily Health Stock News

Please review our Disclaimer and Privacy Policy before subscribing.

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

COPYRIGHT ©2023 HEALTH STOCKS HUB